AIMProteus
AKT Inhibitor Miransertib on Proteus Syndrome - Targeted therapy at NIH is now accepting participant
UPDATES:
NIH only does genetic testing to determine a Proteus syndrome diagnosis; this is typically done by skin biopsy.
For International Participants it is the patients responsibility to verify that passports and visas are valid and up to date.
The first visit is estimated to take up to 1 week with appointments usually scheduled between 8am - 3pm, Monday through Friday.
Lodging during your stay will be at the Children's Inn or local hotels.
Questions about the NIH AIMProteus trial email here or call.
AKT Inhibitor Miransertib on Proteus Syndrome - Targeted therapy at NIH is now accepting participant
UPDATES:
NIH only does genetic testing to determine a Proteus syndrome diagnosis; this is typically done by skin biopsy.
For International Participants it is the patients responsibility to verify that passports and visas are valid and up to date.
The first visit is estimated to take up to 1 week with appointments usually scheduled between 8am - 3pm, Monday through Friday.
Lodging during your stay will be at the Children's Inn or local hotels.
Questions about the NIH AIMProteus trial email here or call.
